Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancer |
Choi, Chi Hwan
(Department of Radiation Oncology, Chungbuk National University College of Medicine)
Kim, Won Dong (Department of Radiation Oncology, Chungbuk National University College of Medicine) Lee, Sang Jeon (Department of Surgery, Chungbuk National University College of Medicine) Park, Woo-Yoon (Department of Radiation Oncology, Chungbuk National University College of Medicine) |
1 | Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 2004;72:15-24. DOI ScienceOn |
2 | Yoon MS, Nam TK, Kim HR, et al. Results of preoperativeconcurrent chemoradiotherapy for the treatment of rectal cancer. J Korean Soc Ther Radiol Oncol 2008;26:247-56. DOI ScienceOn |
3 | Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-40. DOI ScienceOn |
4 | Garcia-Aguilar J, Hernandez de Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 2003;46:298-304. DOI ScienceOn |
5 | Kaminsky-Forrett MC, Conroy T, Luporsi E, et al. Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys 1998;42:935-41. DOI ScienceOn |
6 | Yeo SG, Kim DY, Kim TH, et al. Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic signifi cance of pathologic nodal status (KROG 09- 01). Ann Surg 2010;252:998-1004. DOI ScienceOn |
7 | Yoon SM, Kim DY, Kim TH, et al. Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2007;69:1167-72. DOI ScienceOn |
8 | Das P, Skibber JM, Rodriguez-Bigas MA, et al. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer 2007;109:1750-5. DOI ScienceOn |
9 | Park HC, Janjan NA, Mendoza TR, et al. Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 2009;75:775-81. DOI ScienceOn |
10 | Kalady MF, de Campos-Lobato LF, Stocchi L, et al. Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg 2009;250:582-9. |
11 | Barcellos-Hoff MH, Park C, Wright EG. Radiation and the microenvironment: tumorigenesis and therapy. Nat Rev Cancer 2005;5:867-75. DOI ScienceOn |
12 | Kim JH, Beets GL, Kim MJ, Kessels AG, Beets-Tan RG. Highresolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? Eur J Radiol 2004;52:78-83. DOI ScienceOn |
13 | Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery: the clue to pelvic recurrence? Br J Surg 1982; 69:613-6. DOI ScienceOn |
14 | Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results: EORTC 22921. J Clin Oncol 2005;23:5620-7. DOI ScienceOn |
15 | Green FL, Page DL, Fleming ID, et al. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag; 2002. |
16 | Riesco A. Five-year cancer cure: relation to total amount of peripheral lymphocytes and neutrophils. Cancer 1970;25:135-40. DOI ScienceOn |
17 | Kim US, Papatestas AE, Aufses AH Jr. Prognostic signifi cance of peripheral lymphocyte counts and carcinoembryonic antigens in colorectal carcinoma. J Surg Oncol 1976;8:257-62. DOI ScienceOn |
18 | Lavin PT, Bruckner HW, Plaxe SC. Studies in prognostic factors relating to chemotherapy for advanced gastric cancer. Cancer 1982;50:2016-23. DOI ScienceOn |
19 | O'Toole C, Unsgaard B. Clinical status and rate of recovery of blood lymphocyte levels after radiotherapy for bladder cancer. Cancer Res 1979;39:840-3. |
20 | Kuss I, Hathaway B, Ferris RL, Gooding W, Whiteside TL. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res 2004;10:3755-62. DOI ScienceOn |
21 | Choi CH, Kang H, Kim WY, et al. Prognostic value of baseline lymphocyte count in cervical carcinoma treated with concurrent chemoradiation. Int J Radiat Oncol Biol Phys 2008; 71:199-204. DOI ScienceOn |
22 | Kitayama J, Yasuda K, Kawai K, Sunami E, Nagawa H. Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer. BMC Cancer 2011;11:64. DOI ScienceOn |
23 | Canadas-Garre M, Becerra-Massare P, Lopez de la Torre- Casares M, et al. Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients. Ann Surg 2012;255:986-92. DOI ScienceOn |
24 | Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006;313:1960-4. DOI ScienceOn |
25 | Morris M, Platell C, Iacopetta B. Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fl uorouracil chemotherapy. Clin Cancer Res 2008;14:1413-7. DOI ScienceOn |
26 | Laghi L, Bianchi P, Miranda E, et al. CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study. Lancet Oncol 2009;10:877-84. DOI ScienceOn |
27 | Wieckowski EU, Visus C, Szajnik M, Szczepanski MJ, Storkus WJ, Whiteside TL. Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J Immunol 2009;183:3720-30. DOI ScienceOn |
28 | Miller RA. The aging immune system: primer and prospectus. Science 1996;273:70-4. DOI ScienceOn |
29 | Beets-Tan RG, Beets GL. Rectal cancer: review with emphasis on MR imaging. Radiology 2004;232:335-46. DOI ScienceOn |
30 | Garcia-Aguilar J, Pollack J, Lee SH, et al. Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum 2002;45:10-5. DOI ScienceOn |
31 | de la Torre A, Garcia-Berrocal MI, Arias F, et al. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs.intravenous 5-fl uorouracil and leucovorin. Int J Radiat Oncol Biol Phys 2008;70:102-10. DOI ScienceOn |
32 | Roh MS, Yothers GA, O'Connel MJ, et al. The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04 [abstract]. J Clin Oncol 2011;29(Suppl):3503. DOI |